| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0009 | 1 |